A pill from Structure Therapeutics Inc. helped patients lose roughly as much weight as a rival treatment from Eli Lilly & Co.
The company's investigational GLP-1 treatment performed admirably well in a phase 2b study.
Radar specialist Filippo Biondi says four satellite operators produced identical data showing underground formations ...
Structure's aleniglipron elicited over 11% weight loss in a Phase II trial, sending the biotech's stock up nearly 103% as ...
Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for ...
By Will Dunham WASHINGTON, Dec 8 (Reuters) - Scientists have observed the largest-known rotating structure in the cosmos - a ...
Five people have died in the Eaton fire, and several others have been seriously injured. At least 130,000 residents are under evacuation orders because of the fires in Los Angeles County. Red flag ...